CXCR3 and neoplasm: Indeed, tumor growth reduction achieved by combination treatment was significantly hampered by CXCR3 blockade (p < 0.05, Fig. 3B) and tumor weight distributions clearly visualized the high numbers of large tumors (>1.0 g) and complete absence of small tumors (<0.5 g) (Fig. 3C).